Belinostat clinical trials
Also written PXD101 and Beleodaq.
How each study uses belinostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the belinostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 3 Jul 2014 · BELEODAQ · NDA 206256 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
48 studies that test it; most in 2006 (12)
| Year | Studies |
|---|---|
| 2005 | 3 |
| 2006 | 12 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 31
National Cancer Institute (NCI) (16) · Valerio Therapeutics (9) · Acrotech Biopharma Inc. (6) · University of Utah (3) · Spectrum Pharmaceuticals, Inc (2) · M.D. Anderson Cancer Center (2) · H. Lee Moffitt Cancer Center and Research Institute (1) · Emory University (1)
Often tested with
Tested in the same studies.
Carboplatin (2) · Paclitaxel (2) · Tazemetostat (1) · Pralatrexate (1) · Cyclophosphamide (1) · Doxorubicin (1) · Vincristine (1) · Prednisone (1)
Related medicines
As reviewed, each with the page that says it.
- One of HDAC inhibitors source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 1 phase 3 study under way
Belinostat is the comparator. A study of two new drugs counts under both.
- 1Soquelitinib · Corvus Pharmaceuticals, Inc. · next primary completion Nov 2027
Reaching primary completion within a year · 2
Studies that test belinostat.
- Jun 2027Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentPhase 1 · National Cancer Institute (NCI)
- Jul 2027A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and ToxicityPhase 2 · National Cancer Institute (NCI)
Studies
Open first, then newest update. How each study uses belinostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 48
- A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and ToxicityRecruitingPhase 2National Cancer Institute (NCI)NCT06406465Written as BelinostatHow we know
- Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted TreatmentActive, not recruitingPhase 1National Cancer Institute (NCI)NCT05627245Written as BelinostatHow we know
- MRSI to Predict Response to RT/TMZ ± Belinostat in GBMCompletedPhase 2Emory UniversityNCT02137759Written as BelinostatHow we know
- To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLActive, not recruitingPhase 3Acrotech Biopharma Inc.NCT06072131Written as Belinostat InjectionHow we know
- Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial CarcinomaCompletedPhase 1University of UtahNCT05154994Written as BelinostatHow we know
- Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By GenomicsTerminatedPhase 1University of UtahNCT04315233Written as BelinostatHow we know
- Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaActive, not recruitingPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT05170334Written as BelinostatHow we know
- Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-LymphomaCompletedPhase 2University of MiamiNCT02737046Written as BelinostatHow we know
- Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedPhase 1National Cancer Institute (NCI)NCT03772925Written as BelinostatHow we know
- Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 GenotypesCompletedPhase 1Acrotech Biopharma Inc.NCT02680795Written as Belinostat IVHow we know
- Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerCompletedPhase 1University of Michigan Rogel Cancer CenterNCT04703920Written as BelinostatHow we know
- Belinostat in Relapsed or Refractory Peripheral T-Cell LymphomaCompletedPhase 2Spectrum Pharmaceuticals, IncNCT00865969Written as BelinostatHow we know
- Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof MutationWithdrawnPhase 1University of UtahNCT04315155Written as BelinostatHow we know
- A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung CancerTerminatedPhase 1/2Herlev HospitalNCT01188707Written as Belinostat and ErlotinibHow we know
- MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCCompletedPhase 1/2Acrotech Biopharma Inc.NCT01310244Written as Belinostat, Carboplatin, PaclitaxelHow we know
- Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced CancerCompletedPhase 1Acrotech Biopharma Inc.NCT01583777Written as BelinostatHow we know
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)CompletedPhase 1Acrotech Biopharma Inc.NCT01839097Written as BelinostatHow we know
- To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.TerminatedPhase 1Acrotech Biopharma Inc.NCT02679131Written as BelinostatHow we know
- Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or CisplatinCompletedPhase 2National Cancer Institute (NCI)NCT00993616Written as belinostatHow we know
- Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic DysfunctionCompletedPhase 1National Cancer Institute (NCI)NCT01273155Written as BelinostatHow we know
See all 48 studies that test belinostat →
Given beside what is tested · 5 — belinostat is usual care or a partner of the new treatment
- Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell LymphomaRecruitingPhase 1City of Hope Medical CenterNCT07691450Written as BelinostatHow we know
- Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional ChondrosarcomaActive, not recruitingPhase 2National Cancer Institute (NCI)NCT04340843Written as BelinostatHow we know
- Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid LeukemiaTerminatedPhase 1National Cancer Institute (NCI)NCT02381548Written as BelinostatHow we know
- Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat TrialsCompletedPhase 1Acrotech Biopharma Inc.NCT04184869Written as BelinostatHow we know
- Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other DiseasesCompletedPhase 1National Cancer Institute (NCI)NCT00351975Written as BelinostatHow we know
As the comparator · 2 — what is tested is compared with belinostat
- Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaRecruitingPhase 3Corvus Pharmaceuticals, Inc.NCT06561048Written as BelinostatHow we know
- Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCLRecruitingPhase 2University of VirginiaNCT04747236Written as BelinostatHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Results posted1
- MRSI to Predict Response to RT/TMZ ± Belinostat in GBMOct 30, 2026NCT02137759
Codes
What other systems call belinostat · ClinicalTrials.gg INT004656
- MeSH (NLM) C487081belinostatConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) F4H96P17NZBELINOSTATConfirmed FDA, NLM, Wikidata
- RxNorm 1543543Confirmed FDA, Wikidata
- Wikidata Q4882925belinostatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48812BelinostatConfirmed FDA, Wikidata
- DrugBank DB05015One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C487081 | belinostat | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | F4H96P17NZ | BELINOSTAT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1543543 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4882925 | belinostat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48812 | Belinostat | Confirmed FDA, Wikidata |
| DrugBank | DB05015 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.